SCD and cancer: Incubation with 25-hydroxycholesterol alone did not affect cancer cell proliferation, however co-treatment of cells with the hydroxysterol and CVT-11127 promoted a more profound growth inhibitory effect than with the SCD1 inhibitor alone, an effect likely due to a potentiation of the anti-lipogenic activity of both inhibitors (Fig. 4D).